Masami Yamauchi
Hiroshima, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 85 publications
Complete pathologic response after neoadjuvant immunotherapy for mismatch repair-deficient colon cancer with invading adjacent organs.
Journal: Immunotherapy
Published: May 26, 2026
Management of iron deficiency anemia and the role of intravenous iron supplementation in patients undergoing cancer chemotherapy: a real-world retrospective study in Japan.
Journal: International journal of clinical oncology
Published: November 11, 2025
A prioritization framework for BRCA1/2 variants of uncertain significance identified by comprehensive genomic profiling.
Journal: European journal of human genetics : EJHG
Published: September 30, 2025
Multiomics Analysis of Liver Molecular Dysregulation Leading to Nonviral-Related Hepatocellular Carcinoma Development.
Journal: Journal of proteome research
Published: February 21, 2025
Changes in chemotherapy-induced cognitive impairment in gastrointestinal cancer survivors using multidomain assessments: a prospective cohort study.
Journal: Journal of cancer survivorship : research and practice
Published: October 02, 2024
Successful outcome achieved with adjuvant chemotherapy with irinotecan plus cisplatin in rectal neuroendocrine carcinoma: a case report.
Journal: Surgical case reports
Published: July 24, 2024
Peripheral T Cell Subpopulations as a Potential Surrogate Biomarker during Atezolizumab plus Bevacizumab Treatment for Hepatocellular Carcinoma.
Journal: Cancers
Published: March 17, 2024
Correction: Evaluation of atezolizumab plus bevacizumab combination therapy for hepatocellular carcinoma using contrast-enhanced ultrasonography.
Journal: Journal of medical ultrasonics (2001)
Published: March 11, 2024
Efficacy and safety of atezolizumab plus bevacizumab in patients with portal hypertension for unresectable hepatocellular carcinoma.
Journal: Cancer medicine
Published: October 14, 2023
Association of Hepatobiliary Phase of Gadoxetic-Acid-Enhanced MRI Imaging with Immune Microenvironment and Response to Atezolizumab Plus Bevacizumab Treatment.
Journal: Cancers
Published: July 22, 2023
Sodium-glucose cotransporter-2 inhibitors improve FibroScan-aspartate aminotransferase scores in patients with nonalcoholic fatty liver disease complicated by type 2 diabetes.
Journal: European journal of gastroenterology & hepatology
Published: July 03, 2023
Correction to: Serum interleukin-6 level predicts the prognosis for patients with alcohol-related acute-on-chronic liver failure.
Journal: Hepatology international
Published: May 27, 2023
Last Updated: 09/26/2026